Apparent clinical resolution of pinnal actinic keratoses and squamous cell carcinoma in a cat using topical imiquimod 5% cream

Journal of Feline Medicine and Surgery

Volumn 10, Issue 6, 2008, Pages 593-599

  Peters Kennedy, Jeanine ^a   Scott, Danny W ^a   Miller Jr , William H ^a  

^a Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT; IMIQUIMOD;

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE REPORT; CAT; CAT DISEASE; EXTERNAL EAR; FEMALE; PATHOLOGY; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

AMINOQUINOLINES; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CAT DISEASES; CATS; EAR AURICLE; FEMALE; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 56249110178     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2008.02.002     Document Type: Article

References (38)

1. Abbas A.K., Murphy K.M., and Sher A. Functional diversity of helper T lymphocytes. Nature 383 (1996) 787-793
2. Bensignor E., and Carlotti D.N. Kératose solaire chez deux chiens nus. Point Vét 27 (1995) 263
3. Beutner K.R., Geisse J.K., Helman D., Fox T.L., Geinkel A., and Owens M.L. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. Journal of the American Academy of Dermatology 41 (1999) 1002-1007
4. Bhatai N. Imiquimod as a possible treatment for keratoacanthoma. Journal of Drugs in Dermatology 3 (2004) 71-74
5. Campagne O., Roca M., and Martinez A. Successful treatment of a high-grade intraepithelial neoplasm with imiquimod, with pemphigus vulgaris as a side effect. European Journal of Obstetrical and Gynecology and Reproductive Biology 109 (2003) 224-227
6. Cihocki L.M., Divers T.J., Johnson A.L., Warren A.L., Schramme M., Rassnick K.M., and Scott D.W. A case of multiple epitrichial sweat gland ductal carcinomas in a horse. Veterinary Dermatology 18 (2007) 134-137
7. Clarke R.E. Cryosurgical treatment of feline cutaneous squamous cell carcinoma. Australian Veterinary Practitioner 21 (1991) 148-153
8. Dorn C.R., Taylor D.O.N., and Schneider R. Sunlight exposure and risk of developing cutaneous and oral squamous cell carcinomas in white cats. Journal of the National Cancer Institute 46 (1971) 1073-1078
9. Drummer R., Urosevic M., Kempf W., Krakov D., and Burg G. Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides. Dermatology 207 (2003) 116-118
10. Fidel J.L., Egger E., Blattman H., Oberhänsli F., and Kaser-Hotz B. Proton irradiation of feline nasal planum squamous cell carcinomas using an accelerated protocal. Veterinary Radiology & Ultrasound 42 (2001) 569-575
11. Fox L.E. Feline cutaneous and subcutaneous neoplasms. Veterinary Clinics of North America: Small Animal Practice 25 (1995) 961-979
12. Geisse J., Caro I., Lindholm J., Golitz L., Stampare P., and Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. Journal of the American Academy of Dermatology 50 (2004) 722-733
13. Gill V (2006) Evaluation of imiquimod 5% (Aldara) in cats with multicentric squamous cell carcinoma in situ (MSCCIS). In: Proceedings of the Veterinary Cancer Society.
14. Gomes L.A.M., Ferreira A.M.R., Ferreira de Almeida E., and Paes de Almeida E. Squamous cell carcinoma associated with actinic dermatitis in seven white cats. Feline Practice 28 (2000) 14-16
15. 90Strontium plesiotherapy for feline squamous cell carcinoma of the nasal planum. Journal of Feline Medicine and Surgery 8 (2006) 169-176
16. Hengge U.R., and Schaller J. Successful treatment of invasive squamous cell carcinoma using topical imiquimod. Archives of Dermatology 140 (2004) 404-406
17. Kwochka K.W. Retinoids in dermatology. In: Kirk R.W. (Ed). Current Veterinary Therapy X (1989), WB Saunders, Philadelphia 533
18. Lana S.E., Ogilvie G.K., Withrow S.J., Straw R.C., and Rogers K.S. Feline cutaneous squamous cell carcinoma of the nasal planum and the pinnae: 61 cases. Journal of the American Animal Hospital Association 33 (1997) 329-332
19. Lin R., Ladd D.J., Powell D.J., and Way B.V. Localized pemphigus foliaceus induced by topical imiquimod. Archives of Dermatology 140 (2004) 889-890
20. Lysa B., Tartler U., and Wolf R. Gene expression in actinic keratoses: pharmacological modulation by imiquimod. British Journal of Dermatology 151 (2004) 1150-1159
21. Miller M.A., Nelson S.L., Turk J.R., Pace L.W., Brown T.P., Shaw D.P., Fisher J.R., and Gosser H.S. Cutaneous neoplasia in 340 cats. Veterinary Pathology 28 (1991) 389-395
22. Navi D., and Huntley A. Imiquimod 5 percent cream and the treatment of cutaneous malignancy. Dermatology Online Journal 10 (2004) 4-18
23. Nogueira S.A., Torres S.M., Malone E.D., Diaz S.F., Jessen C., and Gilbert S. Efficacy of imiquimod 5% cream in the treatment of equine sarcoids: a pilot study. Veterinary Dermatology 17 (2006) 259-265
24. Ogilvie G.K., Moore A.S., Obradovich J.E., Elmslie R.E., Vail D.M., Straw R.C., Salmon M.D., Klein M.K., Atwater S.W., and Ciekot P.E. Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumors. Journal of the American Veterinary Medical Association 202 (1993) 1839-1844
25. Oster-Schmidt C. Case report: two cases of squamous cell carcinoma treated with topical imiquimod 5%. Journal of the European Academy of Dermatology and Venereology 18 (2004) 93-95
26. Peaston A.E., Leach M.W., and Higgins R.J. Photodynamic therapy for nasal and aural squamous cell carcinoma in cats. Journal of the American Veterinary Medical Association 202 (1993) 1261-1265
27. Rogers K.S. Feline cutaneous squamous cell carcinoma. Feline Practice 22 (1994) 7-9
28. Savage P., Horton V., Moore J., Owens M., Witt P., and Gore M.E. A phase 1 clinical trial of imiquimod, an oral interferon inducer, administered daily. British Journal of Cancer 74 (1996) 1482-1486
29. Schon M., Bong A.B., and Drewniok C. Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. Journal of the National Cancer Institute 95 (2003) 1138-1149
30. Scott D.W., Miller W.H., and Griffin C.E. Neoplastic and non-neoplastic tumors. Muller & Kirk's Small Animal Dermatology. 6th edn (2001), WB Saunders, Philadelphia 1236-1414
31. Shelley B.A., Bartels K.E., Ely R.W., and Clark D.M. Use of the neodymium-yttrium-aluminum-garnet laser for treatment of squamous cell carcinoma of the nasal planum in a cat. Journal of the American Veterinary Medical Association 201 (1992) 756-758
32. Sigal J.E., Skacal M., Bergfeld W.F., House N.F., Rabkin M.S., and Goldblum J.R. The utility of cytokeratin 5/6 in the recognition of cutaneous spindle cell squamous cell carcinoma. Journal of Cutaneous Pathology 28 (2001) 520-524
33. Smith K.J., Hamza S., and Skelton H. Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte/macrophage populations to a Th1 and M1 cytokine pattern. Clinical and Experimental Dermatology 29 (2004) 505-512
34. Stanley M.A. Imiquimod and the imidazoquinolines: mechanism of action and therapeutic potential. Clinical and Experimental Dermatology 27 (2002) 571-577
35. Stell A.J., Dobsom J.M., and Langmack K. Photodynamic therapy of feline superficial squamous cell carcinoma using topical 5-aminolaevulinic acid. Journal of Small Animal Practice 42 (2001) 164-169
36. Theon A.P., VanVechten M.K., and Madewell B.R. Intratumoral administration of carboplatin for treatment of squamous cell carcinoma of the nasal plane in cats. American Journal of Veterinary Research 2 (1996) 205-210
37. Thomson M. Squamous cell carcinoma of the nasal planum in cats and dogs. Clinical Techniques in Small Animal Practice 22 (2007) 42-45
38. Withrow S.J., and Straw R.C. Resection of the nasal planum in nine cats and five dogs. Journal of the American Animal Hospital Association 26 (1990) 219-222